H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Go back to H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
(NASDAQ: NMRA) Delayed: 1.74 -0.01 (0.57%)
Previous Close $1.75    52 Week High
Open $1.75    52 Week Low
Day High $1.76    P/E N/A 
Day Low $1.70    EPS
Volume 647,465